| Obtain an intensive glycemic control |
| Achieve an intensive control of all associated cardiovascular risk factors |
| When possible, prefer diabetes medications at low risk for hypoglycemia |
| When tolerated, use metformin as the first-line treatment |
| Use SGLT2-inhibitors or GLP-1 receptor agonists in patients with known vascular complications or at high risk for vascular complications |
| Avoid saxagliptin and alogliptin in patients with heart failure or at risk for heart failure |
| Prefer SGLT2 inhibitors in patients with heart failure |
| Deliver to all the patients a structured patient therapeutic education |
| Screen for asymptomatic coronary artery disease and peripheral artery disease |
